Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
$5.63 +0.14 (+2.55%)
Closing price 10/15/2025 04:00 PM Eastern
Extended Trading
$5.65 +0.02 (+0.36%)
As of 10/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACB vs. CGC, CRON, OGI, SNDL, TLRY, VFF, CALT, ARDX, SYRE, and PHVS

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Calliditas Therapeutics AB (publ) (CALT), Ardelyx (ARDX), Spyre Therapeutics (SYRE), and Pharvaris (PHVS).

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, Canopy Growth had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 6 mentions for Canopy Growth and 3 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.12 beat Aurora Cannabis' score of 0.93 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Canopy Growth
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
Canopy Growth
3 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.25

Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
Canopy Growth -155.76%-89.93%-44.24%

Aurora Cannabis has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500.

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$357.88M0.88$1.63M-$0.19-29.63
Canopy Growth$225.65M1.55-$429.86M-$3.03-0.48

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Aurora Cannabis beats Canopy Growth on 11 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$308.66M$10.68B$6.11B$10.45B
Dividend YieldN/A1.91%5.73%4.77%
P/E Ratio-29.6320.5185.3627.36
Price / Sales0.8826.52596.99137.58
Price / Cash8.9825.0737.4661.86
Price / Book0.723.4812.286.81
Net Income$1.63M$208.83M$3.32B$276.80M
7 Day Performance-8.31%-0.59%0.59%0.42%
1 Month Performance12.60%3.16%10.54%7.86%
1 Year Performance1.44%-6.35%70.62%41.24%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.3927 of 5 stars
$5.63
+2.6%
N/A+2.6%$308.66M$357.88M-29.631,130
CGC
Canopy Growth
0.8412 of 5 stars
$1.37
flat
N/A-64.6%$328.59M$225.65M-0.453,150Positive News
CRON
Cronos Group
1.6966 of 5 stars
$2.55
+1.6%
N/A+19.4%$961.06M$117.61M51.00450
OGI
Organigram Global
1.1955 of 5 stars
$1.92
+0.5%
N/A+13.3%$256.59M$117.47M38.41860News Coverage
SNDL
SNDL
3.3051 of 5 stars
$2.48
-1.6%
$4.50
+81.5%
+25.9%$662.20M$671.81M-9.182,516News Coverage
TLRY
Tilray Brands
2.5243 of 5 stars
$1.69
-1.7%
$2.00
+18.3%
+7.0%$1.89B$821.31M-0.742,842Earnings Report
Options Volume
Gap Up
VFF
Village Farms International
1.0239 of 5 stars
$3.46
+4.5%
N/A+270.7%$372.85M$336.18M38.451,400
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
ARDX
Ardelyx
4.327 of 5 stars
$5.01
+1.4%
$11.70
+133.5%
-14.1%$1.19B$333.61M-21.7890Analyst Revision
SYRE
Spyre Therapeutics
3.241 of 5 stars
$18.92
-1.1%
$54.29
+186.9%
-29.5%$1.16B$890K-5.5673Trending News
Analyst Upgrade
Analyst Revision
Gap Up
PHVS
Pharvaris
2.4223 of 5 stars
$22.07
+0.4%
$32.60
+47.7%
+4.6%$1.15BN/A-6.5730News Coverage
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:ACB) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners